Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study-Reference-Cited by-同舟云学术

Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study

Published:2022 Issue:6 Volume:11 Page:2816
ISSN:2249-4863
Container-title:Journal of Family Medicine and Primary Care
language:en
Short-container-title:J Family Med Prim Care

Author:

Misra Puneet,Kant Shashi,Guleria Randeep,Rai SanjayK,Kishore Surekha,Baidya Subrata,Singh ArvindKumar,Chinnakali Palanivel,Medigeshi GuruprasadR,Chaturvedi PradeepKumar,Joshi HariShanker,Mandal Suprakash,Sangral Meenu,Yadav Kapil,Bairwa Mohan,Haldar Partha,Kardam Priyanka,Patil Sharanabasava,Jha Shreya

Publisher

Medknow

Subject

General Materials Science

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of SARS-CoV-2 IgG antibodies among rural children aged 6-14 years in a selected block of West Bengal, India;IMC Journal of Medical Science;2024-07-11

2. Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study;2024-06-10

3. Assessing the Burden of COVID-19 among Children Aged 6-14 Years in Karnataka, India: A Cross-sectional Survey;Indian Journal of Community Medicine;2024-01

4. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post–second wave of pandemic (June to July 2021);Public Health;2023-12

5. Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological Study;Cureus;2023-11-15